Switching from IV to subcutaneous injection eases hard vein access, cuts clinic time, and boosts comfort with faster ...

The FDA review of the biologics license application includes data on SC isatuximab as both manual injection and via an ...

Implementing subcutaneous opioid options in the emergency department significantly reduced reliance on intravenous administration.

As regulators examine the on-body injector used with isatuximab in multiple myeloma, Sikander Ailawadhi, MD, provides ...